Learning Objectives:

  1. Review the burden of the disease - screening recommendations for osteoporosis from endocrine and primary care perspectives
  2. Expanding treatment beyond the bisphosphonates -provide an update on newer osteoanabolic pharmacotherapies for osteoporosis; Bone loss and vertebral fractures after denosumab discontinuation - are there strategies to prevent this?
  3. Provide an Update on Clinical Bone Trials at University of Chicago - PATH Forward, ATOM, WearABLe trials
Session date: 
03/09/2020 - 5:00pm to 6:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Tamara Vokes, M.D. and Meltem Zeytinoglu, M.D., MBA